Skip to main content

VINC

Stock
Health Care
Biotechnology

Performance overview

VINC Price
Price Chart

Forward-looking statistics

Beta
0.59
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

vincerx is a clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer.

Company info

SectorHealth Care
IndustryBiotechnology
Employees24
Market cap$21.0M

Fundamentals

Enterprise value-$4.2M
Revenue$0.0
Revenue per employee—
Profit margin0.00%
Debt to equity0.00

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$5.79
Dividend per share—
Revenue per share$0.00
Avg trading volume (30 day)$3K
Avg trading volume (10 day)$5K
Put-call ratio—

Macro factor sensitivity

Growth+11.0
Credit-3.6
Liquidity-7.0
Inflation+8.1
Commodities+5.1
Interest Rates+1.1

Valuation

Dividend yield0.00%
PEG Ratio-0.06
Price to sales—
P/E Ratio-0.06
Enterprise Value to Revenue—
Price to book0.10

Upcoming events

Next earnings dayMarch 28, 2025
Next dividend day—
Ex. dividend day—

News

What Makes Vincerx Pharma (VINC) a New Buy Stock

Vincerx Pharma (VINC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research (October 10, 2024)
Penny Stock Cancer-Focused Vincerx Pharma Seeks Development Partner For 2 Early-Stage Blood Cancer Candidates

On Monday, Vincerx Pharma VINC shared updates on its ongoing Phase 1 studies of VIP943, VIP236, and enitociclib, which aim to address various blood cancers.

Benzinga (October 8, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free